Tumor growth in SOX18-induced HCC metastasis was significantly inhibited after treatment with BLU-9931, a selective FGFR4 inhibitor, which indicates the significance of FGFR4 in metastatic HCC [77,78]. The gene discussed is FGFR4; the disease is neoplasm.